Treatment of cancer using GFR α-4 chimeric antigen receptor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10851149
APP PUB NO 20170334967A1
SERIAL NO

15503971

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions and methods for treating diseases, disorders or conditions associated with the expression of the Glycosyl-phosphatidylinositol (GPI)-linked GDNF family α-receptor 4 (GFRα4).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF FLORIDA BOARD OF TRUSTEES111 TIGERT HALL GAINESVILLE FL 32611

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhoj, Vijay Philadelphia, US 12 25
Milone, Michael C Cherry Hill, US 73 2761
Rader, Christoph Jupiter, US 41 836
Siegel, Donald L Lansdale, US 26 201

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 1, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 1, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00